Vincent Raussens

Vincent Raussens

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 1999 in Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes
Verified
Journal Article
Closed access
EGErik Goormaghtigh
Erik Goormaghtigh
VRVincent Raussens
Vincent Raussens
JRJean-Marie Ruysschaert
Jean-Marie Ruysschaert

15 July 2009 in Biochemical Journal
Verified
Journal Article
Closed access
PDF file
ECEmilie Cerf
Emilie Cerf
RSRabia Sarroukh
Rabia Sarroukh
STShiori Tamamizu-Kato
Shiori Tamamizu-Kato
LBLeonid Breydo
Leonid Breydo
SDSylvie Derclaye
Sylvie Derclaye
VRVincent Raussens
Vincent Raussens
AD (Alzheimer's disease) is linked to Aβ (amyloid β-peptide) misfolding. Studies demonstrate that the level of soluble Aβ oligomeric forms correlates better with the progression of the disease than the level of fibrillar forms. Conformation-dependent antibodies have been developed to detect either Aβ oligomers or fibrils, suggesting that structural differences between these forms of Aβ exist. Using conditions which yield well-defined Aβ-(1–42) oligomers or fibrils, we studied the secondary structure of these species by ATR (attenuated total reflection)–FTIR (Fouriertransform infrared) spectroscopy. Whereas fibrillar Aβ was organized in a parallel β-sheet conformation, oligomeric Aβ displayed distinct spectral features, which were attributed to an antiparallel β-sheet structure. We also noted striking similarities between Aβ oligomers spectra and those of bacterial outer membrane porins. We discuss our results in terms of a possible organization of the antiparallel β-sheets in Aβ oligomers, which may be related to reported effects of these highly toxic species in the amyloid pathogenesis associated with AD.

1 April 2006 in Biophysical Journal
Verified
Journal Article
Closed access
EGErik Goormaghtigh
Erik Goormaghtigh
JRJean-Marie Ruysschaert
Jean-Marie Ruysschaert
VRVincent Raussens
Vincent Raussens

16 April 2012 in Biochemical Journal
Verified
Journal Article
Closed access
PDF file
MCMaría Soledad Celej
María Soledad Celej
RSRabia Sarroukh
Rabia Sarroukh
EGErik Goormaghtigh
Erik Goormaghtigh
GFGerardo Daniel Fidelio
Gerardo Daniel Fidelio
JRJean-Marie Ruysschaert
Jean-Marie Ruysschaert
VRVincent Raussens
Vincent Raussens
Parkinson's disease is an age-related movement disorder characterized by the presence in the mid-brain of amyloid deposits of the 140-amino-acid protein AS (α-synuclein). AS fibrillation follows a nucleation polymerization pathway involving diverse transient prefibrillar species varying in size and morphology. Similar to other neurodegenerative diseases, cytotoxicity is currently attributed to these prefibrillar species rather than to the insoluble aggregates. Nevertheless, the underlying molecular mechanisms responsible for cytotoxicity remain elusive and structural studies may contribute to the understanding of both the amyloid aggregation mechanism and oligomer-induced toxicity. It is already recognized that soluble oligomeric AS species adopt β-sheet structures that differ from those characterizing the fibrillar structure. In the present study we used ATR (attenuated total reflection)–FTIR (Fourier-transform infrared) spectroscopy, a technique especially sensitive to β-sheet structure, to get a deeper insight into the β-sheet organization within oligomers and fibrils. Careful spectral analysis revealed that AS oligomers adopt an antiparallel β-sheet structure, whereas fibrils adopt a parallel arrangement. The results are discussed in terms of regions of the protein involved in the early β-sheet interactions and the implications of such conformational arrangement for the pathogenicity associated with AS oligomers.

1 November 2003 in Journal of Molecular Biology
Verified
Journal Article
Closed access
NCNicole Choy
Nicole Choy
VRVincent Raussens
Vincent Raussens
VNVasanthy Narayanaswami
Vasanthy Narayanaswami

28 March 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AIAnna Itkin
Anna Itkin
VDVincent Dupres
Vincent Dupres
YDYves Dufrene
Yves Dufrene
BBBurkhard Bechinger
Burkhard Bechinger
JRJean-Marie Ruysschaert
Jean-Marie Ruysschaert
VRVincent Raussens
Vincent Raussens
Amyloid β-peptide (Aβ) is directly linked to Alzheimer's disease (AD). In its monomeric form, Aβ aggregates to produce fibrils and a range of oligomers, the latter being the most neurotoxic. Dysregulation of Ca2+ homeostasis in aging brains and in neurodegenerative disorders plays a crucial role in numerous processes and contributes to cell dysfunction and death. Here we postulated that calcium may enable or accelerate the aggregation of Aβ. We compared the aggregation pattern of Aβ(1–40) and that of Aβ(1–40)E22G, an amyloid peptide carrying the Arctic mutation that causes early onset of the disease. We found that in the presence of Ca2+, Aβ(1–40) preferentially formed oligomers similar to those formed by Aβ(1–40)E22G with or without added Ca2+, whereas in the absence of added Ca2+ the Aβ(1–40) aggregated to form fibrils. Morphological similarities of the oligomers were confirmed by contact mode atomic force microscopy imaging. The distribution of oligomeric and fibrillar species in different samples was detected by gel electrophoresis and Western blot analysis, the results of which were further supported by thioflavin T fluorescence experiments. In the samples without Ca2+, Fourier transform infrared spectroscopy revealed conversion of oligomers from an anti-parallel β-sheet to the parallel β-sheet conformation characteristic of fibrils. Overall, these results led us to conclude that calcium ions stimulate the formation of oligomers of Aβ(1–40), that have been implicated in the pathogenesis of AD.